Novogen Limited KZIA
9.51
(0.27)
(2.76%)
as of 25 Sep
- Market cap
- $111.8M
- P/E
- 0.0×
Follow KZIA
| Older periods | Jun '24 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|---|
| ROE |
+8 more TTM periods Free account |
0.00% | 0.00% | 0.00% | 0.00% |
| ROA | 0.00% | 0.00% | 0.00% | 0.00% | |
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% | |
| Return on Tangible Assets | 0.00% | 0.00% | 0.00% | 0.00% | |
| Average Days of Receivables | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | (26.41) | (26.10) | (24.50) | (26.63) | |
| Capital Expenditures | 0.00 | — | 0.00 | — | |
| Other line items | |||||
| Cash ROIC | 521.24% | 6,636.16% | 1,062.27% | (34.97%) | |
| Accounts Receivable Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Accounts Payable Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Average Days of Payables | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Based Compensation of Revenue | — | 0.00% | — | 0.00% | |
| Operating CF/Net income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Depreciation/Fixed assets | 0.00 | 0.00 | 0.00 | — | |
| Capex/Depreciation | 0.00 | 0.00 | 0.00 | — | |
| Operating CF per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex per Share | 0.00 | — | 0.00 | — | |
| Capex to Sales | 0.00 | — | 0.00 | — |
Columns are period end dates